{
    "nctId": "NCT00591851",
    "briefTitle": "Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility",
    "officialTitle": "Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 70,
    "primaryOutcomeMeasure": "Cardiac Saftey",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* adenocarcinoma breast cancer\n* ECOG performance status of 0 or 1\n* peripheral neuropathy less than or equal to 1\n* discontinued hormonal therapy as a chemoprevention while onstudy\n* LVEF by MUGA \\> 55%?\n* Absolute neutrophil count (ANC)\\> 1000/\u00b5L)\n* platelet count \\> 100,000/\u00b5L)\n* SGOT OR SGPT \\< 92.5 units/L\n\nExclusion Criteria:\n\n* Stage IV breast cancer\n* any chemotherapy, radiation therapy, immunotherapy, or biotherapy for a CURRENT breast cancer\n* pregnant or lactating patients\n* active second malignancy, other than adequately treated non-melanoma skin cancers or in situ cervical cancer\n* previous allergy/hypersensitivity to Doxorubicin, Cyclophosphamide, Paclitaxel, or other drugs formulated in Cremophor EL?\n* unstable angina, congestive heart failure, current use of digitalis, beta-blockers, or calcium blockers for therapy of congestive heart failure, arrhythmia requiring medical therapy, or a history of a myocardial infarction within 12 months\n* psychiatric illness that prevents her from understanding the nature of this study and complying with protocol requirements?\n* active, unresolved infections\n* sensitivity to E. coli derived proteins\n* prior chemotherapy with an anthracycline\n* prior Herceptin therapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}